{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:25:49Z","timestamp":1793665549679,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","award":["Immune Atlas Grant"],"award-info":[{"award-number":["Immune Atlas Grant"]}],"id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Myeloma Solutions Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01589-6","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:07:18Z","timestamp":1783634838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning-based classifier for malignant plasma cell identification in myeloma"],"prefix":"10.1038","volume":"10","author":[{"given":"Sarthak","family":"Satpathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina E.","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Pilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati S.","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1589_CR1","doi-asserted-by":"crossref","unstructured":"Zolotov, E. et al. Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study. Leuk. Lymphoma, 65, 2000\u20132008 (2024).","DOI":"10.1080\/10428194.2024.2385501"},{"key":"1589_CR2","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.21037\/tcr-23-2336","volume":"13","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center. Transl. Cancer Res. 13, 2905\u20132912 (2024).","journal-title":"Transl. Cancer Res."},{"key":"1589_CR3","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","volume":"27","author":"H Avet-Loiseau","year":"2009","unstructured":"Avet-Loiseau, H. et al. Prognostic significance of copy-number alterations in multiple myeloma. J. Clin. Oncol. 27, 4585\u20134590 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1589_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","volume":"125","author":"J Corre","year":"2015","unstructured":"Corre, J., Munshi, N. & Avet-Loiseau, H. Genetics of multiple myeloma: another heterogeneity level? Blood 125, 1870\u20131876 (2015).","journal-title":"Blood"},{"key":"1589_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11680-1","volume":"10","author":"F Maura","year":"2019","unstructured":"Maura, F. et al. Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nat. Commun. 10, 3835 (2019).","journal-title":"Nat. Commun."},{"key":"1589_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/864058","volume":"2014","author":"SM Prideaux","year":"2014","unstructured":"Prideaux, S. M., Conway O\u2019Brien, E. & Chevassut, T. J. The genetic architecture of multiple myeloma. Adv. Hematol. 2014, 864058 (2014).","journal-title":"Adv. Hematol."},{"key":"1589_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/asheducation-2013.1.478","volume":"2013","author":"O Landgren","year":"2013","unstructured":"Landgren, O. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies. Hematol. Am. Soc. Hematol. Educ. Program 2013, 478\u2013487 (2013).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"1589_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1182\/blood-2002-06-1737","volume":"101","author":"F Zhan","year":"2003","unstructured":"Zhan, F. et al. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101, 1128\u20131140 (2003).","journal-title":"Blood"},{"key":"1589_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22804-x","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat. Commun. 12, 2559 (2021).","journal-title":"Nat. Commun."},{"key":"1589_CR10","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","volume":"24","author":"G Ledergor","year":"2018","unstructured":"Ledergor, G. et al. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat. Med. 24, 1867\u20131876 (2018).","journal-title":"Nat. Med."},{"key":"1589_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26598-w","volume":"12","author":"DC Croucher","year":"2021","unstructured":"Croucher, D. C. et al. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. Nat. Commun. 12, 6322 (2021).","journal-title":"Nat. Commun."},{"key":"1589_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00256-021-03754-3","volume":"51","author":"MJ Fitzpatrick","year":"2022","unstructured":"Fitzpatrick, M. J., Nardi, V. & Sohani, A. R. Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing. Skelet. Radiol. 51, 17\u201330 (2022).","journal-title":"Skelet. Radiol."},{"key":"1589_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","volume":"23","author":"S Kumar","year":"2010","unstructured":"Kumar, S., Kimlinger, T. & Morice, W. Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract. Res. Clin. Haematol. 23, 433\u2013451 (2010).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"1589_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","volume":"27","author":"YC Cohen","year":"2021","unstructured":"Cohen, Y. C. et al. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat. Med. 27, 491\u2013503 (2021).","journal-title":"Nat. Med."},{"key":"1589_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao, R. et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat. Biotechnol. 39, 599\u2013608 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1589_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36790-9","volume":"14","author":"A De Falco","year":"2023","unstructured":"De Falco, A., Caruso, F., Su, X. D., Iavarone, A. & Ceccarelli, M. A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data. Nat. Commun. 14, 1074 (2023).","journal-title":"Nat. Commun."},{"key":"1589_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.csbj.2021.01.015","volume":"19","author":"G Pasquini","year":"2021","unstructured":"Pasquini, G., Rojo Arias, J. E., Schafer, P. & Busskamp, V. Automated methods for cell type annotation on scRNA-seq data. Comput. Struct. Biotechnol. J. 19, 961\u2013969 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1589_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07931-2","volume":"10","author":"G Eraslan","year":"2019","unstructured":"Eraslan, G., Simon, L. M., Mircea, M., Mueller, N. S. & Theis, F. J. Single-cell RNA-seq denoising using a deep count autoencoder. Nat. Commun. 10, 390 (2019).","journal-title":"Nat. Commun."},{"key":"1589_CR19","doi-asserted-by":"publisher","unstructured":"Tschannen, M., Bachem, O. & Lucic, M. Recent advances in autoencoder-based representation learning. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1812.05069 (2018).","DOI":"10.48550\/arXiv.1812.05069"},{"key":"1589_CR20","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.csbj.2021.01.027","volume":"19","author":"CM Wilson","year":"2021","unstructured":"Wilson, C. M., Fridley, B. L., Conejo-Garcia, J. R., Wang, X. & Yu, X. Wide and deep learning for automatic cell type identification. Comput. Struct. Biotechnol. J. 19, 1052\u20131062 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1589_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33944-z","volume":"13","author":"R Boiarsky","year":"2022","unstructured":"Boiarsky, R. et al. Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis. Nat. Commun. 13, 7040 (2022).","journal-title":"Nat. Commun."},{"key":"1589_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1182\/blood.2020009754","volume":"138","author":"D Alameda","year":"2021","unstructured":"Alameda, D. et al. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138, 1583\u20131589 (2021).","journal-title":"Blood"},{"key":"1589_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41525-022-00340-x","volume":"8","author":"W Pilcher","year":"2023","unstructured":"Pilcher, W. et al. Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma. NPJ Genom. Med. 8, 3 (2023).","journal-title":"NPJ Genom. Med."},{"key":"1589_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s43018-025-01072-4","volume":"7","author":"WC Pilcher","year":"2026","unstructured":"Pilcher, W. C. et al. A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma. Nat. Cancer 7, 224\u2013246 (2026).","journal-title":"Nat. Cancer"},{"key":"1589_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry, A. et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat. Cancer 4, 27\u201342 (2023).","journal-title":"Nat. Cancer"},{"key":"1589_CR26","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1038\/s41375-025-02748-7","volume":"39","author":"D Ohlstrom","year":"2025","unstructured":"Ohlstrom, D. et al. Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML. Leukemia 39, 2721\u20132734 (2025).","journal-title":"Leukemia"},{"key":"1589_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tig.2020.03.005","volume":"36","author":"CB Azodi","year":"2020","unstructured":"Azodi, C. B., Tang, J. & Shiu, S. H. Opening the black box: interpretable machine learning for geneticists. Trends Genet. 36, 442\u2013455 (2020).","journal-title":"Trends Genet."},{"key":"1589_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/ejh.13766","volume":"109","author":"M Borset","year":"2022","unstructured":"Borset, M. et al. Highly expressed genes in multiple myeloma cells - what can they tell us about the disease? Eur. J. Haematol. 109, 31\u201340 (2022).","journal-title":"Eur. J. Haematol."},{"key":"1589_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102741","volume":"299","author":"M Gomez-Herranz","year":"2023","unstructured":"Gomez-Herranz, M., Taylor, J. & Sloan, R. D. IFITM proteins: understanding their diverse roles in viral infection, cancer, and immunity. J. Biol. Chem. 299, 102741 (2023).","journal-title":"J. Biol. Chem."},{"key":"1589_CR30","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan, F. et al. The molecular classification of multiple myeloma. Blood 108, 2020\u20132028 (2006).","journal-title":"Blood"},{"key":"1589_CR31","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0002-9440(10)62556-4","volume":"160","author":"SA Ely","year":"2002","unstructured":"Ely, S. A. & Knowles, D. M. Expression of CD56\/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am. J. Pathol. 160, 1293\u20131299 (2002).","journal-title":"Am. J. Pathol."},{"key":"1589_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1390105","volume":"14","author":"A Giannakoulas","year":"2024","unstructured":"Giannakoulas, A., Nikolaidis, M., Amoutzias, G. D. & Giannakoulas, N. A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing. Front. Oncol. 14, 1390105 (2024).","journal-title":"Front. Oncol."},{"key":"1589_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0623-y","volume":"18","author":"D Dong","year":"2018","unstructured":"Dong, D., Mu, Z., Zhao, C. & Sun, M. ZFAS1: a novel tumor-related long non-coding RNA. Cancer Cell Int. 18, 125 (2018).","journal-title":"Cancer Cell Int."},{"key":"1589_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02733-5","volume":"22","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. LINC00467: an oncogenic long noncoding RNA. Cancer Cell Int. 22, 303 (2022).","journal-title":"Cancer Cell Int."},{"key":"1589_CR35","doi-asserted-by":"publisher","first-page":"23785","DOI":"10.1002\/jcp.28947","volume":"234","author":"H Yan","year":"2019","unstructured":"Yan, H. et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. J. Cell Physiol. 234, 23785\u201323797 (2019).","journal-title":"J. Cell Physiol."},{"key":"1589_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/bjh.14771","volume":"178","author":"A Russignan","year":"2017","unstructured":"Russignan, A. et al. Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. Br. J. Haematol. 178, 781\u2013793 (2017).","journal-title":"Br. J. Haematol."},{"key":"1589_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06841-0","volume":"12","author":"B Dwivedi","year":"2022","unstructured":"Dwivedi, B., Mumme, H., Satpathy, S., Bhasin, S. S. & Bhasin, M. Survival Genie, a web platform for survival analysis across pediatric and adult cancers. Sci. Rep. 12, 3069 (2022).","journal-title":"Sci. Rep."},{"key":"1589_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101925","volume":"6","author":"LY Moreno Rueda","year":"2025","unstructured":"Moreno Rueda, L. Y. et al. Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets. Cell Rep. Med. 6, 101925 (2025).","journal-title":"Cell Rep. Med."},{"key":"1589_CR39","doi-asserted-by":"publisher","unstructured":"Regev, A. et al. The Human Cell Atlas. Elife 6, https:\/\/doi.org\/10.7554\/eLife.27041 (2017).","DOI":"10.7554\/eLife.27041"},{"key":"1589_CR40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41556-021-00766-y","volume":"23","author":"J Frede","year":"2021","unstructured":"Frede, J. et al. Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nat. Cell Biol. 23, 1199\u20131211 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1589_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1182\/blood.2023022859","volume":"144","author":"A Sobh","year":"2024","unstructured":"Sobh, A. et al. NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome. Blood 144, 283\u2013295 (2024).","journal-title":"Blood"},{"key":"1589_CR42","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","volume":"101","author":"JJ Keats","year":"2003","unstructured":"Keats, J. J. et al. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 101, 1520\u20131529 (2003).","journal-title":"Blood"},{"key":"1589_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-023-01408-6","volume":"16","author":"MH Meeuwsen","year":"2023","unstructured":"Meeuwsen, M. H. et al. Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain. J. Hematol. Oncol. 16, 16 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"1589_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-015-0135-3","volume":"8","author":"S Bustany","year":"2015","unstructured":"Bustany, S., Cahu, J., Descamps, G., Pellat-Deceunynck, C. & Sola, B. Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis. J. Hematol. Oncol. 8, 40 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"1589_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.968208","volume":"12","author":"M Trudu","year":"2022","unstructured":"Trudu, M. et al. Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma. Front. Oncol. 12, 968208 (2022).","journal-title":"Front. Oncol."},{"key":"1589_CR46","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2023.05.007","volume":"41","author":"M Dang","year":"2023","unstructured":"Dang, M. et al. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. Cancer Cell 41, 1032\u20131047 e1034 (2023).","journal-title":"Cancer Cell"},{"key":"1589_CR47","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.gpb.2022.11.011","volume":"20","author":"M Brendel","year":"2022","unstructured":"Brendel, M. et al. Application of deep learning on single-cell RNA sequencing data analysis: a review. Genom. Proteomics Bioinformatics 20, 814\u2013835 (2022).","journal-title":"Genom. Proteomics Bioinformatics"},{"key":"1589_CR48","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 51, D1425\u2013D1431 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1589_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36, 411\u2013420 (2018).","journal-title":"Nat Biotechnol"},{"key":"1589_CR50","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"1589_CR51","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541\u2013D1547 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1589_CR52","doi-asserted-by":"publisher","first-page":"D947","DOI":"10.1093\/nar\/gkaa609","volume":"49","author":"BW Hounkpe","year":"2021","unstructured":"Hounkpe, B. W., Chenou, F., de Lima, F. & De Paula, E. V. HRT Atlas v1.0 database: redefining human and mouse housekeeping genes and candidate reference transcripts by mining massive RNA-seq datasets. Nucleic Acids Res. 49, D947\u2013D955 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1589_CR53","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"1589_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","volume":"4","author":"N Borcherding","year":"2021","unstructured":"Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).","journal-title":"Commun. Biol."},{"key":"1589_CR55","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer International Publishing, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"1589_CR56","unstructured":"Paszke, A. et al. In Proc. 33rd International Conference on Neural Information Processing Systems Article 721 (Curran Associates Inc., 2019)."},{"key":"1589_CR57","first-page":"2122","volume":"5","author":"AT Lun","year":"2016","unstructured":"Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res 5, 2122 (2016).","journal-title":"F1000Res"},{"key":"1589_CR58","unstructured":"Tickle, T., Tirosh, I., Georgescu, C., Brown, M. & Haas, B. inferCNV of the Trinity CTAT Project.. Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA (2019). https:\/\/github.com\/broadinstitute\/inferCNV."},{"key":"1589_CR59","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"1589_CR60","unstructured":"Kassambara, A., Kosinski, M. & Biecek, P. survminer: Drawing Survival Curves using 'ggplot2'. R package version 0.5.2 (2026). https:\/\/rpkgs.datanovia.com\/survminer\/index.html."},{"key":"1589_CR61","doi-asserted-by":"crossref","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model. (Springer, New York, 2000).","DOI":"10.1007\/978-1-4757-3294-8"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01589-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01589-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:31:01Z","timestamp":1793662261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01589-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01589-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B. serves on the board of Canomiks Inc. as chief scientific advisor and has equity in it. S.B. serves as CEO of Anxomics LLC and has equity in it. The other authors do not have a competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"418"}}